Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-25-024372
Filing Date
2025-02-11
Accepted
2025-02-11 16:54:25
Documents
2
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 PRE 14A d930383dpre14a.htm PRE 14A 202136
2 GRAPHIC g930383g0211233100191.jpg GRAPHIC 3675
  Complete submission text file 0001193125-25-024372.txt   208382
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40591 | Film No.: 25610614
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)